A Phase 2 Feasibility Trial of the Oral Direct Thrombin Inhibitor AZD0837 in the Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation, Who Are Unable or Unwilling to Take Warfarin Therapy

Gregory Y. Lip, Lars H. Rasmussen, Sol-Britt Olsson, Sofia Zetterstrand, Christina Stahre, Anders Bylock, Maria Aunes-Jansson, Karin Wahlander

Forskningsoutput: TidskriftsbidragPublicerat konferensabstractPeer review

Originalspråkengelska
Sidor (från-till)S1129-S1129
TidskriftCirculation
Volym120
Utgåva18
StatusPublished - 2009
Evenemang82nd Scientific Session of the American-Heart-Association - Orlando, FL, USA
Varaktighet: 2009 nov. 142009 nov. 18

Ämnesklassifikation (UKÄ)

  • Kardiologi

Citera det här